Product identification
Medicine name:
Rabisin vet. Injektionsvätska, suspension
Active substance:
- Rabies virus, strain G52, Inactivated
Target species:
-
Sheep
-
Dog
-
Horse
-
Cat
-
Cattle
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, strain G52, Inactivated1.00international unit(s)1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Sheep
-
Milk0day
-
Meat and offal0day
-
-
Dog
-
Horse
-
Milk0day
-
Meat and offal0day
-
-
Cat
-
Cattle
-
Milk0day
-
Meat and offal0day
-
-
-
Subcutaneous use
-
Sheep
-
Milk0day
-
Meat and offal0day
-
-
Dog
-
Horse
-
Milk0day
-
Meat and offal0day
-
-
Cat
-
Cattle
-
Milk0day
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Package description:
- Available only in Swedish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Authorisation number:
- 23805
Date of authorisation status change:
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 31/01/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 31/01/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 31/01/2025